BioHandler

About BioHandler

Based in Shanghai, China, BioHandler Life Sci-Tech Co., Ltd. operates as a provider of end-to-end intelligent solutions for the life sciences sector. The company was established in 2020, building on the foundation of Shanghai Triowin Intelligent Machinery Co., Ltd. (founded in 1999) and Triowin Smart Biology (founded in 2017). A significant milestone was achieved in July 2022, when BioHandler secured $14.9 million in an Early Stage Venture Capital funding round involving investors GL Ventures and Proxima Ventures (China).

The firm's core business involves the entire lifecycle of its products, from research and development to production, sales, and service, with a focus on advancing digital intelligence within the industry. BioHandler serves a diverse clientele that includes third-party medical testing centers, hospital laboratories, disease control centers, and biopharmaceutical companies. Its business model is business-to-business (B2B), centered on selling proprietary intelligent automation equipment and providing related services.

BioHandler develops and manufactures intelligent automation equipment, such as a fully automated Next-Generation Sequencing (NGS) library preparation system. This system integrates modules like thermal cyclers, temperature controls, and magnetic stands to automate the library preparation for up to 96 samples, enabling unattended operation. The product portfolio also includes the CANTUS, NEMO, VOLA, and ARCO series of high-throughput liquid handling systems. The company's founding team leverages over a decade of experience in life sciences to create modular and intelligent products for which it holds the intellectual property rights.